Cargando…
Enhanced immunogenic potential of cancer immunotherapy antibodies in human IgG1 transgenic mice
Clinical anti-drug-antibody (ADA) responses represent a substantial obstacle to the development of efficacious therapeutic antibodies. The enhanced ADA production against the idiotype (Id) often displayed by cancer immunotherapy antibodies (CitAbs) can lead to exposure loss and subsequently affect a...
Autores principales: | Egli, Jerome, Heiler, Stefan, Weber, Felix, Steiner, Guido, Schwandt, Timo, Bray-French, Katharine, Klein, Christian, Fenn, Sebastian, Lotz, Gregor P., Opolka-Hoffmann, Eugenia, Kraft, Thomas E., Petersen, Laetitia, Moser, Rebecca, DeGeer, Jonathan, Siegel, Michel, Finke, Daniela, Bessa, Juliana, Iglesias, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673943/ https://www.ncbi.nlm.nih.gov/pubmed/36394299 http://dx.doi.org/10.1080/19420862.2022.2143009 |
Ejemplares similares
-
Validation of a Dendritic Cell and CD4+ T Cell Restimulation Assay Contributing to the Immunogenicity Risk Evaluation of Biotherapeutics
por: Siegel, Michel, et al.
Publicado: (2022) -
The impact of immunogenicity on therapeutic antibody pharmacokinetics: A preclinical evaluation of the effect of immune complex formation and antibody effector function on clearance
por: Opolka-Hoffmann, Eugenia, et al.
Publicado: (2021) -
Immunogenicity of Isogenic IgG in Aggregates and Immune Complexes
por: St. Clair, J. Benjamin, et al.
Publicado: (2017) -
Expanding the MAPPs Assay to Accommodate MHC-II Pan Receptors for Improved Predictability of Potential T Cell Epitopes
por: Hartman, Katharina, et al.
Publicado: (2023) -
The Binding of Human IgG to Minipig FcγRs – Implications for Preclinical Assessment of Therapeutic Antibodies
por: Egli, Jerome, et al.
Publicado: (2019)